XML 73 R97.htm IDEA: XBRL DOCUMENT v3.19.3
Stock-Based Compensation - Stock options (Details) - USD ($)
3 Months Ended 9 Months Ended 12 Months Ended
May 03, 2019
Dec. 31, 2018
Sep. 30, 2019
Sep. 30, 2019
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2016
Jan. 24, 2017
Dec. 29, 2015
Stock Based Compensation                  
Antidilutive securities excluded from computation of diluted net loss per share         15,802,648 5,043,746      
2015 Plan                  
Stock Based Compensation                  
Vesting period         4 years        
Number of shares reserved for issuance under the plan               373,422 311,185
Number of Shares                  
Outstanding at the beginning       2,056,891 506,586 189,189      
Granted       247,275 1,570,136 317,397      
Exercised       (53,963) (5,599)        
Forfeitures       (1,250) (14,232)        
Outstanding at the end   2,056,891 2,248,953 2,248,953 2,056,891 506,586 189,189    
Vested and expected to vest at the end   2,056,891 2,248,953 2,248,953 2,056,891        
Exercisable at the end   242,079 450,866 450,866 242,079        
Weighted Average Exercise Price                  
Outstanding at the beginning (in dollars per share)       $ 4.74 $ 0.94 $ 0.48      
Granted (in dollars per share)       18.18 5.92 1.21      
Exercised (in dollars per share)       1.20 0.84        
Forfeitures (in dollars per share)       7.63 1.11        
Outstanding at the end (in dollars per share)   $ 4.74 $ 6.30 6.30 4.74 $ 0.94 $ 0.48    
Vested and expected to vest at the end (in dollars per share)   4.74 6.30 6.30 4.74        
Exercisable at the end (in dollars per share)   $ 0.88 $ 1.15 $ 1.15 $ 0.88        
Weighted Average Remaining Contractual Life (Years) And Aggregate Intrinsic Value                  
Outstanding (in years)   9 years 4 months 24 days   9 years 1 month 6 days 9 years 4 months 24 days 9 years 8 years 7 months 6 days    
Granted (in years)       10 years 9 years 10 months 24 days        
Exercised (in years)       8 years 1 month 6 days          
Forfeitures (in years)       9 years 6 months          
Outstanding at the beginning (in dollars)       $ 5,946,000 $ 137,000 $ 137,000      
Outstanding at the end (in dollars)   $ 5,946,000 $ 55,305,000 55,305,000 5,946,000 $ 137,000 $ 137,000    
Vested and expected to vest at the end (in dollars)   5,946,000 55,305,000 55,305,000 5,946,000        
Exercisable at the end (in dollars)   $ 1,634,000 $ 12,335,000 $ 12,335,000 $ 1,634,000        
Weighted average grant date fair value per share of stock options granted       $ 11.48 $ 3.80 $ 0.80      
Aggregate intrinsic value of stock options exercised       $ 1,600,000 $ 38,000 $ 0      
2015 Plan | Minimum                  
Stock Based Compensation                  
Share price of common stock on date of grant as a percent of fair market value of company stock (as a percent)     100.00% 100.00%          
2015 Plan | Maximum                  
Stock Based Compensation                  
Term of awards       10 years          
Omnibus Incentive Plan                  
Stock Based Compensation                  
Number of shares reserved for issuance under the plan 2,900,000                
Annual increase in number of share reserved for issuance (as percent) 4.00%                
2015 Plan and 2019 Employee Stock Purchase Plan                  
Stock Based Compensation                  
Vesting period       4 years          
Expiration period       10 years          
2019 Employee Stock Purchase Plan                  
Stock Based Compensation                  
Number of shares reserved for issuance under the plan 240,000   2,653,969 2,653,969          
Annual increase in number of share reserved for issuance (as percent) 1.00%                
Maximum annual increase in shares available for issuance under the plan 480,000                
Option to purchase common stock                  
Stock Based Compensation                  
Antidilutive securities excluded from computation of diluted net loss per share     2,248,953 2,248,953 242,079 64,783